➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: May 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for AT9283

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug AT9283?

AT9283 is an investigational drug.

There have been 5 clinical trials for AT9283. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2010.

The most common disease conditions in clinical trials are Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are NCIC Clinical Trials Group, Cancer Research UK, and Astex Pharmaceuticals.

Recent Clinical Trials for AT9283
AT9283 in Treating Young Patients With Relapsed or Refractory Acute LeukemiaCancer Research UKPhase 1
A Study of AT9283 in Patients With Relapsed or Refractory Multiple MyelomaNCIC Clinical Trials GroupPhase 2
AT9283 in Children and Adolescents With Relapsed and Refractory Solid TumorsCancer Research UKPhase 1

See all AT9283 clinical trials

Clinical Trial Summary for AT9283

Top disease conditions for AT9283
Top clinical trial sponsors for AT9283

See all AT9283 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.